HK1162669A1 - Pacap as a marker for cancer pacap - Google Patents

Pacap as a marker for cancer pacap

Info

Publication number
HK1162669A1
HK1162669A1 HK12103033.9A HK12103033A HK1162669A1 HK 1162669 A1 HK1162669 A1 HK 1162669A1 HK 12103033 A HK12103033 A HK 12103033A HK 1162669 A1 HK1162669 A1 HK 1162669A1
Authority
HK
Hong Kong
Prior art keywords
pacap
marker
cancer
cancer pacap
Prior art date
Application number
HK12103033.9A
Other languages
English (en)
Chinese (zh)
Inventor
Marie Luise Hagmann
Johann Karl
Julia Kloeckner
Markus Roessler
Michael Tacke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1162669A1 publication Critical patent/HK1162669A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK12103033.9A 2008-11-12 2012-03-27 Pacap as a marker for cancer pacap HK1162669A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08019731 2008-11-12
PCT/EP2009/008006 WO2010054789A1 (fr) 2008-11-12 2009-11-10 Pacap en tant que marqueur pour le cancer

Publications (1)

Publication Number Publication Date
HK1162669A1 true HK1162669A1 (en) 2012-08-31

Family

ID=40217266

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12103033.9A HK1162669A1 (en) 2008-11-12 2012-03-27 Pacap as a marker for cancer pacap

Country Status (8)

Country Link
US (1) US20110212464A1 (fr)
EP (1) EP2356461B1 (fr)
JP (1) JP5172020B2 (fr)
CN (1) CN102209899B (fr)
CA (1) CA2742286C (fr)
ES (1) ES2439966T3 (fr)
HK (1) HK1162669A1 (fr)
WO (1) WO2010054789A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102375057A (zh) * 2010-08-10 2012-03-14 复旦大学 一种均相荧光同时检测多种血清标志物的方法
WO2014004931A1 (fr) 2012-06-27 2014-01-03 Berg Pharma Llc Utilisation de marqueurs dans le diagnostic et le traitement du cancer de la prostate
WO2015100353A1 (fr) * 2013-12-27 2015-07-02 Dignity Health Diagnostic et traitement de la maladie d'alzheimer
US20160178631A1 (en) * 2014-08-22 2016-06-23 Abbott Laboratories Methods for the early detection of colorectal cancer
AU2015360694B2 (en) 2014-12-08 2021-10-14 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
CA2971589C (fr) 2014-12-18 2021-09-28 Edico Genome Corporation Transistor a effet de champ chimiquement sensible
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
AU2016249140B8 (en) * 2015-04-16 2022-07-21 H. Lundbeck A/S. Anti-PACAP antibodies and uses thereof
CN105891482B (zh) * 2016-03-29 2017-12-19 复旦大学附属中山医院 一种基于生物标志物谱针对中国农村人口肺结节人群的肺癌风险预测模型
SG10202109689QA (en) 2016-04-15 2021-10-28 Alder Biopharmaceuticals Inc Humanized anti-pacap antibodies and uses thereof
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
EP3459115A4 (fr) 2016-05-16 2020-04-08 Agilome, Inc. Dispositifs à fet au graphène, systèmes et leurs méthodes d'utilisation pour le séquençage d'acides nucléiques
US20200299779A1 (en) * 2019-02-13 2020-09-24 Epigenomics Ag Methods for detecting head and neck cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5389096A (en) 1996-04-11 1997-10-29 Human Genome Sciences, Inc. Human hematopoietic-specific protein
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer
JP3691798B2 (ja) * 2002-02-18 2005-09-07 三洋化成工業株式会社 血液中の腫瘍マーカー定量方法
CN101111768A (zh) * 2004-11-30 2008-01-23 维里德克斯有限责任公司 肺癌预后
MX2007006441A (es) 2004-11-30 2007-08-14 Johnson & Johnson Prognosis de cancer de pulmon.
WO2006121991A2 (fr) 2005-05-06 2006-11-16 Diadexus, Inc. Compositions, et methodes de detection, de pronostic et de traitement du cancer du sein
US20100009905A1 (en) 2006-03-24 2010-01-14 Macina Roberto A Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer
WO2007130423A2 (fr) * 2006-05-01 2007-11-15 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Marqueurs biologiques de tissu de plaie chronique et méthodes d'utilisation pour des critères de débridement chirurgical
ES2384125T3 (es) * 2007-03-23 2012-06-29 F. Hoffmann-La Roche Ag Apex como marcador de cáncer de pulmón

Also Published As

Publication number Publication date
EP2356461A1 (fr) 2011-08-17
JP2012508385A (ja) 2012-04-05
ES2439966T3 (es) 2014-01-27
JP5172020B2 (ja) 2013-03-27
US20110212464A1 (en) 2011-09-01
EP2356461B1 (fr) 2013-10-09
CA2742286C (fr) 2016-08-09
CA2742286A1 (fr) 2010-05-20
WO2010054789A1 (fr) 2010-05-20
CN102209899A (zh) 2011-10-05
CN102209899B (zh) 2014-05-07

Similar Documents

Publication Publication Date Title
HK1162669A1 (en) Pacap as a marker for cancer pacap
GB2459228B (en) Exosome-associated microrna as a diagnostic marker
GB2460769C (en) TLE3 as a marker for chemotherapy
GB0717101D0 (en) Tumour marker
PL2176664T3 (pl) Ccr4 jako marker nowotworowy
HK1166130A1 (en) Use of s-erbb-3 as a marker for cancer s-erbb-3
HK1170566A1 (en) Secernin-1 as a marker for cancer -1
GB0724412D0 (en) Marker
EP2252357A4 (fr) Stylet orientable
AU320441S (en) Marker
ZA201200888B (en) New tumor marker
GB0714573D0 (en) Marker gene
HK1160218A1 (en) Asc as a marker for lung cancer asc
GB2477687B (en) X-ray marker
GB0908071D0 (en) Marker
GB0905964D0 (en) Marker
IL220316A (en) Mitf as a marker of cancer tendency
GB0809689D0 (en) Markers for prostate cancee
GB0707671D0 (en) Fiducial marker
GB2450971B (en) A page marker
GB0800637D0 (en) Evidence marker
GB0703654D0 (en) Sterimatic dose marker
GB0807961D0 (en) Renal cancer marker
GB0724775D0 (en) A marker
ZA200905006B (en) Exosome-Associated microrna as a diagnostic marker

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181110